[Masaru Yoshida] Cancer diagnosis/drug efficiency evaluation biomarker research by comprehensive metabolomics/targeted proteomics and establishment of innovative integrated clinical diagnosis network


Research Director

Masaru Yoshida

Masaru Yoshida

Division of Metabolomics Research, Department of Internal Medicine related, Graduate School of Medicine, Kobe University
Associate Professor


Outline

In this study, we search the protein/metabolite biomarkers for cancer diagnosis and drug efficiency evaluation/toxicity prediction by using high quality clinical samples that are collected on the basis of ‘Standard Operating Procedure’, and next validate their biomarkers. Moreover, we develop the medical devices to measure the biomarkers found in our study. Then, we establish the medical cloud system innovative integrated clinical diagnosis network, and next lead to development of the new model for next generation diagnosis system.

Quick Access

Program

  • CREST
  • PRESTO
  • ACT-I
  • ERATO
  • ACT-C
  • ACCEL
  • ALCA
  • RISTEX
Finish programs
  • Pamphlet
  • ProjectDB
  • GlobalActivity
  • Diversity-EN
  • OS_Policy-EN
  • Question-E